NCEL

Conviction 57HealthcareScan · Thu, Jun 25, 2026

Bullish engulfing

NCEL$3.59+1.41%

ResistanceSupportVol 14Insider buy

Vol MA14 16.69K

Mar 25Apr 13Apr 30May 18Jun 5Jun 24

NewcelX Ltd.Biotechnologywww.newcelx.com ↗

Price3.59

Change+1.41%

Gap-2.82%

Rel volume0.07×

Avg volume65.33K

Avg $ vol223.29K

SMA 203.31

SMA 503.35

SMA 200—

Price vs 50+7.16%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 3.92

RSI (14)60

MACD hist0.04

MACD crossbull · 2d

Stoch %K / %D98 / 93

ADX (14)13

+DI / −DI20 / 13

RSI divergence—

MACD divergence—

ATR %+7.71%

ADR %8.16%

52w high7.29

52w low1.88

From 52w high-50.75%

Above 52w low+90.96%

New 52w highNo

SqueezeOn · 18d

Bollinger width20.99%

%B0.91

Donchian pos87.78%

Donchian high3.70

Donchian low2.80

AVWAP (52w high)3.53

vs AVWAP high+1.73%

AVWAP (52w low)3.52

vs AVWAP low+2.11%

OBV trendUp

Chaikin MF (20)0.32

Today vs 20d0.07×

Avg vol (14d)16.69K

Avg vol (20d)65.33K

Avg $ vol (20d)223.29K

Market cap17.22M

RS 3m (vs SPY)+36.09%

RS 6m (vs SPY)+30.34%

RS line new highNo

Trend template—

Technical rank88.1

1 week+11.84%

1 month+13.61%

3 months+48.35%

6 months+38.08%

1 year—

YTD+71.77%

P/E—

P/B2.38

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq0.05

Current0.76

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value15.38M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out5.35M

Employees4

ListedTue, Jan 26, 2021

Free float2.42M

Float %45.2%

Short interest75.32K

Days to cover0.7d

Short volume10.1%

Squeeze score10 / 100

Next earningsThu, Jul 30, 2026 (35d)

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction57 / 100

Pattern quality—

Tech rank88.1 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Congress activity

Disclosed STOCK Act trades in NCEL

All disclosures →

No recent disclosed trades by Congress in NCEL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NCEL · 4 buys

Insider	Side	Shares	Value	Traded	Filed
Revel Michel CSO and Director · Warrant (right to buy) · 2026-04-27	Buy	76.36K	—	2026-04-27	2026-04-29
Samuel Olivier Director · Warrant (right to buy) · 2026-04-27	Buy	114.55K	—	2026-04-27	2026-04-29
Samuel Olivier Director · Common Shares, par value CHF 0.05 per share · 2026-04-27	Buy	81.82K	$225K	2026-04-27	2026-04-29
Revel Michel CSO and Director · Common Shares, par value CHF 0.05 per share · 2026-04-27	Buy	54.55K	$150K	2026-04-27	2026-04-29

SEC filings

EDGAR filings in NCEL · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.